Skip to content

AIM-PD-L1

AI-based Measurement of PD-L1, available for lung, head and neck, melanoma, and urothelial cancers

Detect and quantify PD-L1 positive tumor and immune cells while optimizing your digital pathology workflow.

AIM-PD-L1 NSCLC

AIM-PD-L1 NSCLC is multi-clone and multi-scanner compatible

Specifications:

  • Intended Use: Research Use Only
  • Indications: Non-small Cell Lung Cancer
  • Clones: Agilent Dako 28-8 and 22C3; Roche Ventana SP142 and SP263
  • Scanners: Leica Aperio® AT2 and GT450; Philips UFS, Roche DP200, Hamamatsu NanoZoomer® s360
  • Inputs: Biopsy and/or resection sample from primary, lymph node,  or metastatic tumor
  • Outputs: Percent PD-L1 positive tumor cells and proportion of PD-L1+ cells to all cancer cells; cell counts and proportion across cell classes in different tissue regions

AIM-PD-L1 HNSCC

Specifications:

  • Intended Use: Research Use Only
  • Indications: Head and Neck Squamous Cell Carcinoma
  • Clones: Agilent Dako 28-8
  • Scanners: Leica Aperio® AT2 and GT450; Philips UFS, Roche DP200, Hamamatsu NanoZoomer® s360
  • Inputs: Biopsy and/or resection sample from primary, lymph node,  or metastatic tumor
  • Outputs: Percent PD-L1 positive tumor cells and proportion of PD-L1+ cells to all cancer cells; cell counts and proportion across cell classes in different tissue regions

AIM-PD-L1 Melanoma

Specifications:

  • Intended Use: Research Use Only
  • Indications: Melanoma
  • Clones: Agilent Dako 28-8
  • Scanners: Leica Aperio® AT2 and GT450; Philips UFS, Roche DP200, Hamamatsu NanoZoomer® s360
  • Inputs: Biopsy and/or resection sample from primary, lymph node,  or metastatic tumor
  • Outputs: Percent PD-L1 positive tumor cells and proportion of PD-L1+ cells to all cancer cells; cell counts and proportion across cell classes in different tissue regions

AIM-PD-L1 UC

Specifications:

  • Intended Use: Research Use Only
  • Indications: Urothelial Carcinoma
  • Clones: Agilent Dako 28-8
  • Scanners: Leica Aperio® AT2 and GT450; Philips UFS, Roche DP200, Hamamatsu NanoZoomer® s360
  • Inputs: Biopsy and/or resection sample from primary, lymph node,  or metastatic tumor
  • Outputs: Percent PD-L1 positive tumor cells and proportion of PD-L1+ cells to all cancer cells; cell counts and proportion across cell classes in different tissue regions
PD-L1-monitor1

Contact Us

Connect with our team to learn more about AIM-PD-L1

1AIM-PD-L1 is for Research Use Only. Not for use in diagnostic procedures.